Nabihah Tayob
Harvard University
H-index: 27
North America-United States
Top articles of Nabihah Tayob
Germline and somatic fumarate hydratase testing in atypical uterine leiomyomata
Cancer Prevention Research
2024/5/2
Nabihah Tayob
H-Index: 13
Sarah J Hill
H-Index: 7
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancer
NPJ Breast Cancer
2024/4/16
Abstract CT008: A phase 2, two-stage study of mirvetuximab soravtansine (IMGN853) in combination with pembrolizumab in patients with microsatellite stable (MSS) recurrent or …
Cancer Research
2024/4/5
Niya Xiong
H-Index: 5
Nabihah Tayob
H-Index: 13
Martin Hayes
H-Index: 6
Panagiotis Konstantinopoulos
H-Index: 39
Prognosis and treatment outcomes for patients with stage IA triple-negative breast cancer
NPJ Breast Cancer
2024/4/4
Filipa Lynce
H-Index: 13
Nabihah Tayob
H-Index: 13
TP53-associated early breast cancer: new observations from a large cohort
JNCI: Journal of the National Cancer Institute
2024/4/3
Nabihah Tayob
H-Index: 13
Hepatocellular Carcinoma Screening in a Contemporary Cohort of At-Risk Patients
JAMA Network Open
2024/4/1
Nabihah Tayob
H-Index: 13
Neehar Parikh
H-Index: 29
Distinctive profile of monomeric and polymeric anti-SSA/Ro52 immunoglobulin A1 isoforms in saliva of patients with primary Sjögren’s syndrome and Sicca
RMD open
2024/4/1
Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial
Nature Communications
2024/3/19
Abstract A061: Detection and dynamic monitoring of clonal hematopoiesis mutations in women receiving systemic therapies for high grade serous ovarian carcinoma
Cancer Research
2024/3/4
Nabihah Tayob
H-Index: 13
Elizabeth Lee
H-Index: 3
Alexi Wright
H-Index: 38
Panagiotis Konstantinopoulos
H-Index: 39
Abstract A083: Personalized targeted circulating tumor DNA (ctDNA) and T-cell responses after combined neoantigen vaccine and immune checkpoint blockade in ovarian cancer
Cancer Research
2024/3/4
Nabihah Tayob
H-Index: 13
Derin Keskin
H-Index: 24
Catherine Wu
H-Index: 1
Panagiotis Konstantinopoulos
H-Index: 39
Abstract B013: Folate receptor alpha (FRa) expression and correlation with other molecular alterations in high grade serous endometrial cancer (EC)
Clinical Cancer Research
2024/3/1
Niya Xiong
H-Index: 5
Nabihah Tayob
H-Index: 13
Elizabeth Lee
H-Index: 3
Panagiotis Konstantinopoulos
H-Index: 39
Axillary nodal response to neoadjuvant T-DM1 combined with pertuzumab in a prospective phase II multi-institution clinical trial
Journal of the American College of Surgeons
2024/3/1
Qingchun Jin
H-Index: 0
Nabihah Tayob
H-Index: 13
Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer
JAMA oncology
2024/2/29
Nabihah Tayob
H-Index: 13
Abstract PO2-11-02: Incidence, treatment patterns and outcomes of breast cancer during the first year of the COVID pandemic: A population-based study
Cancer Research
2024/5/2
Evolution of HER2-low expression between pretreatment biopsy and residual disease after neoadjuvant therapy for breast cancer
European Journal of Cancer
2024/2/10
Nabihah Tayob
H-Index: 13
Abstract PO1-03-08: Association of patient-reported triple-negative breast cancer (TNBC) knowledge with clinical trial participation
Cancer Research
2024/5/2
A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer
Breast Cancer Research and Treatment
2024/2
Nabihah Tayob
H-Index: 13
Abstract PO3-01-09: Results of a prospective observational study evaluating the impact of the Prosigna assay on neoadjuvant treatment decision-making in patients with early …
Cancer Research
2024/5/2
Prevalence, Dynamics, and Prognostic Role of Clonal Hematopoiesis of Indeterminate Potential in Patients With Breast Cancer
Journal of Clinical Oncology
2024/1/8
Abstract PO3-03-05: Clinical outcomes in early-stage TNBC according to HER2-low status
Cancer Research
2024/5/2
